StockNews.com Begins Coverage on VolitionRx (NYSE:VNRX)

StockNews.com initiated coverage on shares of VolitionRx (NYSE:VNRX – Free Report) in a research note issued to investors on Saturday. The firm issued a sell rating on the stock. Separately, Cantor Fitzgerald reaffirmed an overweight rating and set a $2.50 price target on shares of VolitionRx in a research report on Wednesday, March 27th. Get […]

Related Keywords

United States , ,Volitionrx Limited ,Cantor Fitzgerald ,Securities Exchange Commission ,Volitionrx Company Profile ,Silverberg Bernstein Capital Management ,Free Report ,Get Free Report ,Bernstein Capital Management ,Volitionrx Daily ,Volitionrx ,Nyse Vnrx ,Vnrx ,Medical ,Initiated Coverage ,Stocknews Com ,